.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent data from Sweden highlights a significant shift in the management of metastatic castration-sensitive prostate cancer (mCSPC). Between 2017 and 2023, the treatment landscape evolved rapidly. Researchers observed a substantial increase in the time to disease progression. This improvement directly correlates with the wider adoption of intensified therapeutic regimens. Specifically, the use of doublet and triplet therapies became the new clinical standard during this period.
A nationwide cohort study included 2,421 patients with de novo metastatic castration-sensitive prostate cancer. The results demonstrated that the median time to progression or death rose from 19.9 months to 30.0 months. Furthermore, the proportion of patients receiving initial intensified therapy increased from 42.5% to 68.8%. Consequently, these findings suggest that aggressive early intervention effectively delays the transition to castration resistance. Similarly, clinicians in India are increasingly following global guidelines that prioritize such combinations over androgen deprivation therapy (ADT) alone.
While the study showed improved progression-free periods, the median overall survival (OS) remained stable at approximately 49.8 months. However, delaying progression is a critical goal for many patients. It helps maintain a better quality of life for a longer duration. Moreover, the study indicates that comorbidities and co-medication use remain important factors in treatment sequencing. Doctors should therefore tailor therapy based on individual risk profiles and disease volume.
Intensification using doublets or triplets delays disease progression. It also improves the time spent in the castration-sensitive phase, which usually offers a better quality of life compared to the castration-resistant stage.
Common intensified treatments include combining androgen deprivation therapy (ADT) with an androgen receptor signaling inhibitor (ARSI) or docetaxel chemotherapy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare guidance. Always consult a qualified physician for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Styrke J et al. Treatment and progression of patients in Sweden with metastatic castration-sensitive prostate cancer. Acta Oncol. 2026 May 21. doi: 10.2340/1651-226X.2026.45110. PMID: 42165189.
Indian Council of Medical Research (ICMR). Consensus Document for Management of Prostate Cancer. 2022. Available at: icmr.gov.in
Fizazi K et al. Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2026;37(5):590-607.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Swedish registry data shows that intensified therapy for mCSPC has significantly increased the time to disease progression from 19.9 to 30.0 months....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
